Last updated: 07/31/2025 10:10:14
Post-marketing study to assess the risk of intussusception (IS) after immunization with Rotarix PCV-free liquid vaccine in infants less than 1 year old in Latin America
GSK study ID
212329
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Will be recruiting
Will be recruiting
Trial overview
Official title: Post-marketing study to assess the risk of intussusception after immunization with GlaxoSmithKline (GSK) Biologicals’ oral live-attenuated human rotavirus vaccine in infants less than 1 year old in Latin America
Trial description: This study aims to evaluate the risk of intussusception, after vaccination with GSK Biologicals’ oral rotavirus vaccine in infants under 1 year old across 5 to 8 countries in Latin America.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Number of participants with definite IS exposed to a first dose of Rotavirus (RV) vaccination
Timeframe: Up to 7 days post-dose 1
Secondary outcomes:
Number of participants with definite IS exposed to a second dose of RV vaccination
Timeframe: Up to 7 days post-dose 2
Occurrence of definite IS during one of the 4 intervals after the first dose of RV vaccine among vaccinated subjects
Timeframe: From Day 1 to 7, Day 8 to 14, Day 15 to 21, and Day 22 to 35
Interventions:
Not applicable
Enrollment:
2600
Primary completion date:
2027-28-05
Observational study model:
Case-Control
Time perspective:
Prospective
Clinical publications:
Not applicable
- Inclusion criteria for enrolment of IS cases:
- All IS cases must satisfy ALL the following criteria at study entry:
- Exclusion criteria for enrolment of IS cases:
- The following criteria should be checked at the time of study entry. If ANY exclusion criterion applies, the IS case must not be included in the study:
Inclusion and exclusion criteria
Inclusion criteria:
- A male or female participants aged at least 6 weeks old and less than 1 year at the time of diagnosis of definite IS (participants are ineligible before 6 weeks of age and as of their first birthday).
- Participant hospitalized or visiting the ER of the participating hospitals during the study period for definite IS.
- Participant whose parent(s)/Legally Acceptable Representative(s) (LAR[s]), in the opinion of the investigator, can and will comply with the requirements of the protocol (e.g., agree to provide vaccination status during contact follow-up if not available at enrolment visit).
- Participant whose parent(s)/LAR(s), provide written informed consent (according to applicable local regulations). Inclusion criteria for enrolment of controls: All control participants must satisfy ALL the following criteria at study entry:
- A male or female participant aged at least 6 weeks old and less than 1 year at the time of hospitalization or visit to the hospital outpatient clinic or ER (participants are ineligible before 6 weeks of age and as of their first birthday).
- Participant hospitalized or visiting the hospital outpatient clinic or the ER of the participating hospitals during the study period with no gastro-intestinal symptoms (including gastro-enteritis and IS).
- Participant whose parent(s)/LAR(s), in the opinion of the investigator, can and will comply with the requirements of the protocol (e.g., agree to provide vaccination status during contact follow-up if not available at enrolment visit).
- Participant whose parent(s)/LAR(s), provide written informed consent (according to applicable local regulations).
Inclusion criteria for enrolment of IS cases: All IS cases must satisfy ALL the following criteria at study entry:
Exclusion criteria:
- Participant has previously participated as a case or a control in this study, either in the same hospital or in another participating hospital.
- Participant is enrolled in another clinical trial. Exclusion criteria for enrolment of controls: The following criteria should be checked at the time of study entry. If ANY exclusion criterion applies, the control must not be included in the study:
- Participant has previously participated as a case or a control in this study, either in the same hospital or in another participating hospital.
- Participant is enrolled in another clinical trial.
- Participant has gastro-intestinal symptoms (including gastro-enteritis and IS) during current hospitalization/visit to the hospital outpatient clinic or ER, at the time of enrolment visit.
Exclusion criteria for enrolment of IS cases: The following criteria should be checked at the time of study entry. If ANY exclusion criterion applies, the IS case must not be included in the study:
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
No study documents available.
Results overview
No study documents available
Recruitment status
Will be recruiting
Actual primary completion date
Not applicable
Actual study completion date
Not applicable
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website